0001209191-13-057711.txt : 20131218
0001209191-13-057711.hdr.sgml : 20131218
20131218162253
ACCESSION NUMBER: 0001209191-13-057711
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20131216
FILED AS OF DATE: 20131218
DATE AS OF CHANGE: 20131218
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CADENCE PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001333248
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12481 HIGH BLUFF DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 8584361400
MAIL ADDRESS:
STREET 1: 12481 HIGH BLUFF DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: AKER HAZEL M
CENTRAL INDEX KEY: 0001265783
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33103
FILM NUMBER: 131285439
MAIL ADDRESS:
STREET 1: C/O CANCER VAX CORP
STREET 2: 2110 RUTHERFORD ROAD
CITY: CARLSBAD
STATE: CA
ZIP: 92008
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2013-12-16
0
0001333248
CADENCE PHARMACEUTICALS INC
CADX
0001265783
AKER HAZEL M
C/O CADENCE PHARMACEUTICALS, INC.
12481 HIGH BLUFF DRIVE, SUITE 200
SAN DIEGO
CA
92130
0
1
0
0
SVP, GC & Secretary
common stock
2013-12-16
4
M
0
13014
3.51
A
16759
D
common stock
2013-12-16
4
S
0
13014
8.76
D
3745
D
stock option (right to buy)
3.51
2013-12-16
4
M
0
13014
D
2022-03-14
common stock
13014
109451
D
The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2013.
25% of the 155,000 shares of common stock originally subject to the option vested on 03/14/2013, and 1/48th of the remaining number of shares of common stock subject to the option vested on the first day of each full month thereafter.
Not applicable to this transaction.
/s/ Hazel M. Aker
2013-12-18